A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients

Clinical trial NCT02589275 · COMPLETED

Trial details

NCT number: NCT02589275
Sponsor: Tonix Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Fibromyalgia

Start date: 2015-08-04
Primary completion: 2016-09-28
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.